These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

99 related items for PubMed ID: 17588360

  • 1. [High prevalence of left ventricular hypertrophy in patients with hypertension of long course].
    Fernández Villaverde JM, Maestro Saavedra FJ, Allut Vidal G, Grigorian Shamagian L, Otero-Raviña F, González-Juanatey JR, Grupo Barbanza.
    Med Clin (Barc); 2007 Jun 09; 129(2):46-50. PubMed ID: 17588360
    [Abstract] [Full Text] [Related]

  • 2. [Electrocardiographic criteria for left ventricular hypertrophy and cardiovascular risk in hypertensives. VIIDA study].
    González-Juanatey JR, Cea-Calvo L, Bertomeu V, Aznar J, for Investigators study VIIDA.
    Rev Esp Cardiol; 2007 Feb 09; 60(2):148-56. PubMed ID: 17338880
    [Abstract] [Full Text] [Related]

  • 3. Detection of left ventricular hypertrophy by different electrocardiographic criteria in clinical practice. Findings from the Sara study.
    Calderón A, Barrios V, Escobar C, Ferrer E, Barrios S, González-Pedel V, Montoro P, Navarro-Cid J.
    Clin Exp Hypertens; 2010 May 09; 32(3):145-53. PubMed ID: 20504121
    [Abstract] [Full Text] [Related]

  • 4. Effect of obesity on electrocardiographic left ventricular hypertrophy in hypertensive patients : the losartan intervention for endpoint (LIFE) reduction in hypertension study.
    Okin PM, Jern S, Devereux RB, Kjeldsen SE, Dahlöf B, LIFE Study Group.
    Hypertension; 2000 Jan 09; 35(1 Pt 1):13-8. PubMed ID: 10642268
    [Abstract] [Full Text] [Related]

  • 5. Serial evaluation of electrocardiographic left ventricular hypertrophy for prediction of risk in hypertensive patients.
    Okin PM.
    J Electrocardiol; 2009 Jan 09; 42(6):584-8. PubMed ID: 19631946
    [Abstract] [Full Text] [Related]

  • 6. Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events.
    Okin PM, Devereux RB, Jern S, Kjeldsen SE, Julius S, Nieminen MS, Snapinn S, Harris KE, Aurup P, Edelman JM, Wedel H, Lindholm LH, Dahlöf B, LIFE Study Investigators.
    JAMA; 2004 Nov 17; 292(19):2343-9. PubMed ID: 15547161
    [Abstract] [Full Text] [Related]

  • 7. Regression of electrocardiographic left ventricular hypertrophy or strain is associated with lower incidence of cardiovascular morbidity and mortality in hypertensive patients independent of blood pressure reduction - A LIFE review.
    Bang CN, Devereux RB, Okin PM.
    J Electrocardiol; 2014 Nov 17; 47(5):630-5. PubMed ID: 25052475
    [Abstract] [Full Text] [Related]

  • 8. Relation of echocardiographic left ventricular mass and hypertrophy to persistent electrocardiographic left ventricular hypertrophy in hypertensive patients: the LIFE Study.
    Okin PM, Devereux RB, Jern S, Julius S, Kjeldsen SE, Dahlöf B.
    Am J Hypertens; 2001 Aug 17; 14(8 Pt 1):775-82. PubMed ID: 11497193
    [Abstract] [Full Text] [Related]

  • 9. Determinants and prognostic significance of electrocardiographic left ventricular hypertrophy criteria in chronic kidney disease.
    Agarwal R, Light RP.
    Clin J Am Soc Nephrol; 2011 Mar 17; 6(3):528-36. PubMed ID: 21088286
    [Abstract] [Full Text] [Related]

  • 10. [Prevalence of left ventricular hypertrophy, atrial fibrillation and cardiovascular disease in hypertensive patients of Andalusia, Spain. PREHVIA study].
    Martín-Rioboó E, García Criado E, Pérula De Torres LA, Cea-Calvo L, Anguita Sánchez M, López Granados A, Ureña Fernández T, García Matarín L, Molina Díaz R, en representación del Grupo de Hipertensión Arterial de la Sociedad Andaluza de Medicina Familiar y Comunitaria (SAMFyC) y de los investigadores del estudio PREHVIA.
    Med Clin (Barc); 2009 Feb 28; 132(7):243-50. PubMed ID: 19248873
    [Abstract] [Full Text] [Related]

  • 11. Baseline characteristics in relation to electrocardiographic left ventricular hypertrophy in hypertensive patients: the Losartan intervention for endpoint reduction (LIFE) in hypertension study. The Life Study Investigators.
    Okin PM, Devereux RB, Jern S, Kjeldsen SE, Julius S, Dahlöf B.
    Hypertension; 2000 Nov 28; 36(5):766-73. PubMed ID: 11082141
    [Abstract] [Full Text] [Related]

  • 12. [Left ventricular hypertrophy in the Spanish hypertensive population. The ERIC-HTA study].
    Lozano JV, Redón J, Cea-Calvo L, Fernández-Pérez C, Navarro J, Bonet A, González-Esteban J.
    Rev Esp Cardiol; 2006 Feb 28; 59(2):136-42. PubMed ID: 16540035
    [Abstract] [Full Text] [Related]

  • 13. Obesity and ECG left ventricular hypertrophy.
    Muiesan ML, Salvetti M, Di Castelnuovo A, Paini A, Assanelli D, Costanzo S, Badilini F, Vaglio M, Donati MB, Agabiti Rosei E, de Gaetano G, Iacoviello L, Moli-sani Study Investigators.
    J Hypertens; 2017 Jan 28; 35(1):162-169. PubMed ID: 27662187
    [Abstract] [Full Text] [Related]

  • 14. Combining ECG Criteria for Left Ventricular Hypertrophy Improves Risk Prediction in Patients With Hypertension.
    Okin PM, Hille DA, Kjeldsen SE, Devereux RB.
    J Am Heart Assoc; 2017 Nov 18; 6(11):. PubMed ID: 29151037
    [Abstract] [Full Text] [Related]

  • 15. Prevalence of left ventricular hypertrophy detected by Cornell voltage-duration product in a hypertensive population.
    Barrios V, Escobar C, Calderon A, Ribas L, Marti D, Asin E.
    Blood Press; 2008 Nov 18; 17(2):110-5. PubMed ID: 18568700
    [Abstract] [Full Text] [Related]

  • 16. [Left ventricular hypertrophy in black African subjects with artery hypertension: Results of a cross-sectional survey conducted in semi-rural area in Senegal].
    Mbaye A, Dodo B, Ngaïde AA, Sy NF, Babaka K, Mingou JS, Faye M, Niang K, Sarr SA, Dioum M, Bodian M, Ndiaye MB, Kane AD, Ndour-Mbaye M, Diao M, Diack B, Kane M, Diagne-Sow D, Thiaw I, Kane A.
    Ann Cardiol Angeiol (Paris); 2017 Sep 18; 66(4):210-216. PubMed ID: 28554700
    [Abstract] [Full Text] [Related]

  • 17. Standard electrocardiographic criteria for left ventricular hypertrophy in Nigerian hypertensives.
    Dada A, Adebiyi AA, Aje A, Oladapo OO, Falase AO.
    Ethn Dis; 2005 Sep 18; 15(4):578-84. PubMed ID: 16259479
    [Abstract] [Full Text] [Related]

  • 18. Regression of electrocardiographic left ventricular hypertrophy is associated with less hospitalization for heart failure in hypertensive patients.
    Okin PM, Devereux RB, Harris KE, Jern S, Kjeldsen SE, Julius S, Edelman JM, Dahlöf B, LIFE Study Investigators.
    Ann Intern Med; 2007 Sep 04; 147(5):311-9. PubMed ID: 17785486
    [Abstract] [Full Text] [Related]

  • 19. Relationship of left ventricular systolic function to persistence or development of electrocardiographic left ventricular hypertrophy in hypertensive patients: implications for the development of new heart failure.
    Okin PM, Wachtell K, Gerdts E, Dahlöf B, Devereux RB.
    J Hypertens; 2014 Dec 04; 32(12):2472-8; discussion 2478. PubMed ID: 25340854
    [Abstract] [Full Text] [Related]

  • 20. Electrocardiographic left ventricular hypertrophy regression induced by an angiotensin receptor blocker-based regimen in hypertensive patients with diabetes: data from the SARA study.
    Barrios V, Escobar C, Calderón A, Echarri R, Barrios S, Navarro-Cid J.
    J Renin Angiotensin Aldosterone Syst; 2009 Sep 04; 10(3):168-73. PubMed ID: 19651760
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.